Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®
Elaine S. DeMeyer, MSN, RN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC and has been a nurse entrepreneur for more than two decades. Elaine leverages her healthcare background along with creativity, business knowledge, and collaborative relationships.
Her mission through beyond Oncology is: To improve patient care by empowering oncology professionals with the tools and resources to change practice.
Articles by Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®
There are 5 types of immune-mediated cytopenias, each with provisional diagnostic criteria.
Nurses have a critical role in managing cGVHD-related serositis, including patient assessment, direct care, and education.
Since TAC levels must remain in a therapeutic range, oncology nurses often draw blood levels before the morning dose.
Although the term “atypical cGVHD” is imperfect, it describes a form of cGVHD that doesn’t fit neatly into classic ...
Currently, there is no standardization of melphalan administration.
With 3 FDA-approved BiTEs for myeloma, oncology nurses must be able to understand BiTEs and explain them to patients.
Misinformation or fake news can mislead patients with multiple myeloma.
Nurse researchers noted patients had “feelings of confusion at the time of initial diagnosis" of multiple myeloma.
Although CRAB describes end-organ symptoms of multiple myeloma, it does not provide a full picture.
Myeloma is a complex blood cancer that can be difficult to comprehend, especially the 2 earlier precursor disease stages.
Oncology nurses must be able to quickly identify hypercalcemia because it can cause cardiac arrest or coma.
Hypercalcemia is the most common oncologic emergency, which makes it critical to understand this electrolyte imbalance.
The GI tract, commonly called “the gut,” is a frequent target of GVHD, in particular aGVHD.
Dealing with the long-term, life-altering, uncomfortable symptoms of chronic GVHD can be difficult to accept.
As the care team members with the most patient contact, oncology nurses must understand shared decision-making.
As patients may be considering or receiving anti-BCMA therapy, oncology nurses need to be able to explain this target.
Muscle cramps are among the lesser-known manifestations of cGVHD, but can have debilitating symptoms.
Recent studies suggest that up to 75% of patients report muscle cramps and that the cramps can last up to 30 minutes.
Oncology nurses must understand these diverse manifestations and their potential impact on patients’ daily lives.
Nearly 1 of 5 patients (18%) with cGVHD had kidney dysfunction, with 8% having moderate-severe dysfunction.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.